Enanta Pharmaceuticals Inc SEC filings ENTA
Enanta Pharmaceuticals Inc has 835 filings in SEC EDGAR's recent list, going back to Jun 21, 2002. Its latest annual report, Form ARS, was filed on Jan 26, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (other events). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 28, 2026 | Oct 28, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 27, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 4 | Insider transaction | Aug 10, 2026 | Aug 8, 2026 |
| 8-K |
Current report
Material agreement
|
Jul 2, 2026 | Jul 2, 2026 |
| 424B5 | Prospectus supplement | Jul 2, 2026 | — |
| 8-K |
Current report
Other events
|
Jun 23, 2026 | Jun 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 18, 2026 | Jun 18, 2026 |
| S-8 | Employee stock plan registration | May 13, 2026 | — |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 11, 2026 | May 11, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| 8-K |
Current report
Other events
|
Mar 26, 2026 | Mar 20, 2026 |
| 4 | Insider transaction | Mar 13, 2026 | Mar 11, 2026 |
| 4 | Insider transaction | Mar 13, 2026 | Mar 11, 2026 |
| 4 | Insider transaction | Mar 13, 2026 | Mar 11, 2026 |
| 4 | Insider transaction | Mar 13, 2026 | Mar 11, 2026 |
| 4 | Insider transaction | Mar 13, 2026 | Mar 11, 2026 |
| 4 | Insider transaction | Mar 13, 2026 | Mar 11, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Mar 12, 2026 | Mar 11, 2026 |
| EFFECT | Filing | Feb 20, 2026 | — |
| CORRESP | Letter to the SEC | Feb 17, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 17, 2026 | — |
| 4 | Insider transaction | Feb 13, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 12, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| S-3 | Shelf registration | Feb 11, 2026 | — |
| 10-Q | Quarterly report | Feb 11, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 9, 2026 | Feb 9, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2026 | — |
| ARS | Annual report to shareholders | Jan 26, 2026 | Sep 30, 2025 |
| DEFA14A | Additional proxy material | Jan 26, 2026 | — |
| DEF 14A | Proxy statement | Jan 26, 2026 | Mar 11, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 20, 2026 | — |
| 4 | Insider transaction | Dec 5, 2025 | Dec 5, 2025 |
| 4 | Insider transaction | Dec 5, 2025 | Dec 5, 2025 |
| 4 | Insider transaction | Dec 5, 2025 | Dec 5, 2025 |
| 4 | Insider transaction | Dec 5, 2025 | Dec 5, 2025 |
| 4 | Insider transaction | Dec 5, 2025 | Dec 5, 2025 |
| 4 | Insider transaction | Dec 5, 2025 | Dec 5, 2025 |
| 4 | Insider transaction | Dec 5, 2025 | Dec 5, 2025 |
| 144 | Notice of proposed sale | Dec 5, 2025 | — |
| 4 | Insider transaction | Dec 3, 2025 | Dec 1, 2025 |
| 4 | Insider transaction | Dec 3, 2025 | Dec 1, 2025 |
| 4 | Insider transaction | Dec 3, 2025 | Dec 1, 2025 |
| 4 | Insider transaction | Dec 3, 2025 | Dec 1, 2025 |
| 4 | Insider transaction | Dec 3, 2025 | Dec 1, 2025 |
| 4 | Insider transaction | Dec 3, 2025 | Dec 1, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Nov 25, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Nov 25, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Nov 25, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Nov 25, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Nov 25, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Nov 25, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Nov 25, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Nov 25, 2025 |
| 10-K | Annual report | Nov 19, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 17, 2025 | Nov 17, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 13, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 7, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 9, 2025 | — |
| 8-K |
Current report
Other events
|
Oct 1, 2025 | Sep 30, 2025 |
| 424B5 | Prospectus supplement | Oct 1, 2025 | — |
| 424B5 | Prospectus supplement | Sep 30, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 29, 2025 | Sep 29, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 29, 2025 | Sep 29, 2025 |
| 3 | Initial insider ownership | Sep 8, 2025 | Aug 26, 2025 |
| 3 | Initial insider ownership | Sep 8, 2025 | Aug 26, 2025 |
| 8-K |
Current report
Officer or director change
|
Aug 27, 2025 | Aug 26, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 20, 2025 | Aug 20, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2025 | Aug 11, 2025 |
| 4 | Insider transaction | Aug 8, 2025 | Aug 8, 2025 |
| S-8 | Employee stock plan registration | May 14, 2025 | — |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 17, 2025 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Mar 17, 2025 | Mar 13, 2025 |
| 4 | Insider transaction | Mar 14, 2025 | Mar 13, 2025 |
| 4 | Insider transaction | Mar 14, 2025 | Mar 13, 2025 |
| 4 | Insider transaction | Mar 14, 2025 | Mar 13, 2025 |
| 4 | Insider transaction | Mar 14, 2025 | Mar 13, 2025 |
| 4 | Insider transaction | Mar 14, 2025 | Mar 13, 2025 |
| 4 | Insider transaction | Mar 14, 2025 | Mar 13, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 14, 2025 | — |
| 4 | Insider transaction | Feb 14, 2025 | Feb 12, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 12, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 12, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 12, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 12, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 12, 2025 |
| 4 | Insider transaction | Feb 12, 2025 | Feb 12, 2025 |
| 10-Q | Quarterly report | Feb 12, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 11, 2025 | — |
| 8-K |
Current report
Results of operations
|
Feb 10, 2025 | Feb 10, 2025 |
| ARS | Annual report to shareholders | Jan 27, 2025 | Sep 30, 2024 |
| DEFA14A | Additional proxy material | Jan 27, 2025 | — |
| DEF 14A | Proxy statement | Jan 27, 2025 | Mar 13, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 22, 2025 | — |
| 4 | Insider transaction | Dec 10, 2024 | Dec 6, 2024 |
| 4 | Insider transaction | Dec 10, 2024 | Dec 6, 2024 |
| 4 | Insider transaction | Dec 10, 2024 | Dec 6, 2024 |
| 4 | Insider transaction | Dec 10, 2024 | Dec 6, 2024 |
| 4 | Insider transaction | Dec 10, 2024 | Dec 6, 2024 |
| 4 | Insider transaction | Dec 10, 2024 | Dec 6, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 9, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 3, 2024 | Dec 1, 2024 |
| 4 | Insider transaction | Dec 3, 2024 | Dec 1, 2024 |
| 4 | Insider transaction | Dec 3, 2024 | Dec 1, 2024 |
| 4 | Insider transaction | Dec 3, 2024 | Dec 1, 2024 |
| 4 | Insider transaction | Dec 3, 2024 | Dec 1, 2024 |
| 4 | Insider transaction | Nov 27, 2024 | Nov 27, 2024 |
| 4 | Insider transaction | Nov 27, 2024 | Nov 27, 2024 |
| 4 | Insider transaction | Nov 27, 2024 | Nov 27, 2024 |
| 4 | Insider transaction | Nov 27, 2024 | Nov 27, 2024 |
| 4 | Insider transaction | Nov 27, 2024 | Nov 27, 2024 |
| 4 | Insider transaction | Nov 27, 2024 | Nov 27, 2024 |
| 4 | Insider transaction | Nov 27, 2024 | Nov 27, 2024 |
| 10-K | Annual report | Nov 27, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 25, 2024 | Nov 25, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 17, 2024 | — |
| 4 | Insider transaction | Aug 9, 2024 | Aug 8, 2023 |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2024 | Aug 5, 2024 |
| 4 | Insider transaction | Jul 15, 2024 | Jul 11, 2024 |
| 144 | Notice of proposed sale | Jul 11, 2024 | — |
| 4 | Insider transaction | Jun 17, 2024 | Jun 17, 2024 |
| 144 | Notice of proposed sale | Jun 17, 2024 | — |
| S-8 | Employee stock plan registration | May 8, 2024 | — |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 6, 2024 | May 6, 2024 |
| 4 | Insider transaction | May 1, 2024 | Apr 29, 2024 |
| 3 | Initial insider ownership | May 1, 2024 | Apr 29, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Mar 12, 2024 | Mar 6, 2024 |
| 4 | Insider transaction | Mar 8, 2024 | Mar 6, 2024 |
| 4 | Insider transaction | Mar 8, 2024 | Mar 6, 2024 |
| 4 | Insider transaction | Mar 8, 2024 | Mar 6, 2024 |
| 4 | Insider transaction | Mar 8, 2024 | Mar 6, 2024 |
| 4 | Insider transaction | Mar 8, 2024 | Mar 6, 2024 |
| 4 | Insider transaction | Mar 8, 2024 | Mar 6, 2024 |
| 4 | Insider transaction | Feb 27, 2024 | Feb 26, 2024 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 27, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 26, 2024 | — |
| 4 | Insider transaction | Feb 14, 2024 | Feb 12, 2024 |
| 4 | Insider transaction | Feb 14, 2024 | Feb 12, 2024 |
| 4 | Insider transaction | Feb 14, 2024 | Feb 12, 2024 |
| 4 | Insider transaction | Feb 14, 2024 | Feb 12, 2024 |
| 4 | Insider transaction | Feb 14, 2024 | Feb 12, 2024 |
| 4 | Insider transaction | Feb 14, 2024 | Feb 12, 2024 |
| 4 | Insider transaction | Feb 14, 2024 | Feb 12, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| CORRESP | Letter to the SEC | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| EFFECT | Filing | Feb 8, 2024 | — |
| 10-Q | Quarterly report | Feb 8, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 7, 2024 | Feb 7, 2024 |
| UPLOAD | Letter from the SEC | Feb 7, 2024 | — |
| CORRESP | Letter to the SEC | Feb 6, 2024 | — |
| ARS | Annual report to shareholders | Jan 26, 2024 | Sep 30, 2023 |
| DEFA14A | Additional proxy material | Jan 26, 2024 | — |
| DEF 14A | Proxy statement | Jan 26, 2024 | Mar 6, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 26, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 24, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 22, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jan 11, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Dec 26, 2023 | Dec 19, 2023 |
| 4 | Insider transaction | Dec 15, 2023 | Dec 13, 2023 |
| 144 | Notice of proposed sale | Dec 12, 2023 | — |
| 4 | Insider transaction | Dec 6, 2023 | Dec 5, 2023 |
| 4 | Insider transaction | Dec 6, 2023 | Dec 5, 2023 |
| 4 | Insider transaction | Dec 6, 2023 | Dec 5, 2023 |
| 4 | Insider transaction | Dec 6, 2023 | Dec 5, 2023 |
| 4 | Insider transaction | Dec 6, 2023 | Dec 5, 2023 |
| 4 | Insider transaction | Dec 6, 2023 | Dec 5, 2023 |
| 4 | Insider transaction | Dec 6, 2023 | Dec 5, 2023 |
| 4 | Insider transaction | Dec 5, 2023 | Dec 1, 2023 |
| 4 | Insider transaction | Dec 5, 2023 | Dec 1, 2023 |
| 4 | Insider transaction | Dec 5, 2023 | Dec 1, 2023 |
| 4 | Insider transaction | Dec 5, 2023 | Dec 1, 2023 |
| 4 | Insider transaction | Dec 5, 2023 | Dec 1, 2023 |
| 4 | Insider transaction | Dec 5, 2023 | Dec 1, 2023 |
| UPLOAD | Letter from the SEC | Nov 27, 2023 | — |
| 4 | Insider transaction | Nov 22, 2023 | Nov 22, 2023 |
| 4 | Insider transaction | Nov 22, 2023 | Nov 22, 2023 |
| 4 | Insider transaction | Nov 22, 2023 | Nov 22, 2023 |
| 4 | Insider transaction | Nov 22, 2023 | Nov 22, 2023 |
| 4 | Insider transaction | Nov 22, 2023 | Nov 22, 2023 |
| 4 | Insider transaction | Nov 22, 2023 | Nov 22, 2023 |
| 4 | Insider transaction | Nov 22, 2023 | Nov 22, 2023 |
| S-3 | Shelf registration | Nov 22, 2023 | — |
| 10-K | Annual report | Nov 22, 2023 | Sep 30, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ENTA (Nasdaq)
- Fiscal year ends
- September 30
- Headquarters
- Watertown, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1177648
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.